Form 4: Twist Bioscience Chief Accounting Officer Sells Shares to Cover Tax Obligations

Twist Bioscience Corp.'s Chief Accounting Officer, Robert F. Werner, sold 839 shares of common stock for $27.728 per share to satisfy tax withholding obligations related to Restricted Stock Unit vesting.

Summary

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp. (TWST), reported a transaction on May 23, 2025.
• The transaction involved the disposition of 839 shares of common stock.
• The shares were sold at a price of $27.728 per share.
• This sale was a 'sell to cover' transaction, mandated by the issuer's equity incentive plans to fund tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• The sale was not a discretionary trade by Mr. Werner.
• Following this transaction, Mr. Werner beneficially owns 50,191 shares of Twist Bioscience common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it involves a sale of shares, it is explicitly stated as a non-discretionary 'sell to cover' transaction for tax obligations related to RSU vesting, which is a positive sign of employee compensation and retention. It does not indicate a lack of confidence from the insider.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs), which is a form of employee compensation and retention, suggesting that employees are being rewarded for their tenure and performance.

Negatives

• The sale, while non-discretionary, results in a slight reduction of direct insider ownership in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

Insider transactions, particularly 'sell to cover' sales related to RSU vesting, are common occurrences across all industries, including biotechnology. They are typically non-discretionary and are a standard mechanism for employees to cover tax liabilities arising from equity compensation.

Comparison to Industry Standards

• The 'sell to cover' mechanism for tax withholding on RSU vesting is a widely adopted practice among publicly traded companies, including those in the biotechnology sector like Twist Bioscience.
• This method is comparable to practices seen in companies such as Illumina (ILMN) or Pacific Biosciences of California (PACB) where equity compensation is a significant part of executive and employee remuneration.

Stakeholder Impact

• Shareholders: The sale represents a minor dilution of ownership, but it is a routine event for executive compensation.
• Employees: The vesting of RSUs indicates the company's commitment to its equity incentive plans, which benefits employees.

Key Dates

Keywords

Twist Bioscience, TWST, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Executive Compensation, Biotechnology